Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Immunity|June 1, 1995
Limited capacity for tolerization of CD4+ T cells specific for a pancreatic beta cell neo-antigenI Förster, R Hirose, J M Arbeit, et al.The EMBO Journal|May 15, 1995
A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma developmentM D Vivanco, R Johnson, P E Galante, et al.Cancer Research|April 10, 1999
Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular functionJ Grunstein, W G Roberts, O Mathieu-Costello, et al.Cell|September 20, 1991
Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcomaJ Kandel, E Bossy-Wetzel, F Radvanyi, et al.Princess Takamatsu Symposia|January 1, 1989
Tumorigenic latency and separable stages during fibrosarcoma development in transgenic mice carrying papillomavirus genomesD Hanahan, E Wetzel, J Skowronski, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Specific chromosomal abnormalities characterize fibrosarcomas of bovine papillomavirus type 1 transgenic miceV Lindgren, M Sippola-Thiele, J Skowronski, et al.Science (New York, N.Y.)|March 12, 1993
Betacellulin: a mitogen from pancreatic beta cell tumorsY Shing, G Christofori, D Hanahan, et al.Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Antiangiogenic therapy of transgenic mice impairs de novo tumor growthS Parangi, M O'Reilly, G Christofori, et al.Diabetes|April 1, 1990
Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumorA C Powers, S Efrat, S Mojsov, et al.Development (Cambridge, England)|February 1, 1996
Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factorsG K Gittes, P E Galante, D Hanahan, et al.Pageof 11